Search for: "Miquel Montañá" Results 81 - 94 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2018, 8:45 am by Miquel Montañá
Miquel Montañ;áAs most readers will know, yesterday the European Commission published a proposal to amend Regulation 469/2009 concerning the supplementary protection certificate for medicinal products (the “SPC Regulation”) aimed at introducing a so-called “manufacturing exemption for export purposes” (in short, a “manufacturing waiver”). [read post]
31 May 2018, 8:52 pm by Miquel Montañá
Miquel Montañ;áAs most readers will know, yesterday the European Commission published a proposal to amend Regulation 469/2009 concerning the supplementary protection certificate for medicinal products (the “SPC Regulation”) aimed at introducing a so-called “manufacturing exemption for export purposes” (in short, a “manufacturing waiver”). [read post]
26 Nov 2018, 2:09 am by Miquel Montañá
Miquel Montañ;áIn its judgment of 25 July 2018 (Case C-121/17 Teva v. [read post]
7 Aug 2016, 12:41 am by Miquel Montañá
Miquel Montañ;áClifford ChanceAs readers know well, one of the issues carefully considered by courts around the world when examining inventive activity is the qualifications and experience of the experts designated by the parties to illustrate to the court what the understanding of the hypothetical “person skilled in the art” would have been on the priority date of the patent examined. [read post]
9 Sep 2019, 4:39 am by Miquel Montañá
Miquel Montañ;áAs readers are well aware, one of the difficult tasks when applying article 69 of the European Patent Convention (“EPC”) and its Protocol of Interpretation is to strike the right balance between “interpreting” the claims in the context of the specification, while, at the same time, avoiding “importing” features of the specification into the claims. [read post]
13 Dec 2019, 12:42 am by Miquel Montañá
Miquel Montañ;áIn view of the upcoming Christmas season, in light of a judgment of 15 October 2019 from the Court of Appeal of Valencia published recently, a call for caution for Father Christmas is in order. [read post]
11 Jul 2019, 10:20 am by Miquel Montañá
Miquel Montañ;áOne of the principles inherited from Roman law is that “venire contra factum propium non valet“. [read post]
11 Sep 2019, 1:00 pm by Oswin Ridderbusch
Oswin Ridderbusch and Alexa von UexküllIn the field of supplementary protection certificates (SPCs) in the European Union, the majority of all CJEU referrals resolved to date have dealt with the interpretation of the – presumably simple – requirement that an SPC can be only granted for an active ingredient (or a combination of active ingredients) that is “protected” by the basic patent relied upon. [read post]
21 Jan 2019, 4:21 am by Miquel Montañá
Miquel Montañ;áAs discussed in our blog of 30 May 2018, the EU Commission has proposed an amendment to Regulation (EC) 469/2009 concerning the supplementary protection certificate for medicinal products (“SPC Regulation”) aimed at introducing a “manufacturing for export exception. [read post]
6 Jan 2024, 1:24 am by Kluwer Patent blogger
, the number 7 in the list, Miquel Montañ;á of Clifford Chance discusses the German dominance of the new European court: ‘In reality, we are not seeing a cosmopolitan court but a German court or, to be more precise, a Munich court, which begs the question as to whether the UPC should be renamed the Unified Munich Court (“UMC”). [read post]